Home > Insider Trading > Filing (0001477449-24-000150)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477449	Teladoc Health Inc.	TDOC	Services-Offices & Clinics Of Doctors Of Medicine (8011)	043705970

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1918441	Vidya Raman-Tangella	C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-05-31	792	$0.00	29,952	No	4	M	Direct
Common Stock	Acquisiton	2024-05-31	2,325	$0.00	32,277	No	4	M	Direct
Common Stock	Disposition	2024-05-31	3,407	$11.21	28,870	No	4	S	Direct
Common Stock	Disposition	2024-06-03	1,122	$11.16	27,748	No	4	S	Direct
Common Stock	Disposition	2024-06-04	468	$11.04	27,280	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Stock Units	Disposition	2024-05-31	792	$0.00	792	$0.00
Common Stock	Restricted Stock Units	Disposition	2024-05-31	2,325	$0.00	2,325	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,548			No	4	M	Direct
16,277			No	4	M	Direct

Footnotes

Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 1, 2024.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
On March 1, 2024, the reporting person earned 9,509 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 3, 2023, the reporting person was granted 27,902 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.